Search results
Results from the WOW.Com Content Network
Feline hypertrophic cardiomyopathy (HCM) is the most common heart disease in domestic cats; [71] [72] [73] the disease process and genetics are believed to be similar to the disease in humans. [74] In Maine Coon cats, HCM has been confirmed as an autosomal dominant inherited trait. [75] Numerous cat breeds have HCM as a problem in the breed. [76]
Feline disease refers to infections or illnesses that affect cats. They may cause symptoms, sickness or the death of the animal. Some diseases are symptomatic in one cat but asymptomatic in others. Feline diseases are often opportunistic and tend to be more serious in cats that already have concurrent sicknesses.
It is a diagnosis of exclusion which means other possible urinary diseases which could cause bladder inflammation (e.g. feline urinary tract infections or urolithiasis) are ruled out. [5] Research is still being pursued regarding the causes of cystitis in cats, though the following principal risk factors have been identified: [14]
Up to 17% of cats with HCM experience arterial thromboembolism, but cats with other cardiomyopathies are also at increased risk. Cats with abnormally increased hemostasis, which can occur with hyperthyroidism, tumors, extensive inflammation, blood poisoning (sepsis), injury, or disseminated intravascular coagulation, represent another risk ...
The most common cause of FLUTD in cats less than 10 years of age is non-obstructive feline idiopathic cystitis. Less common causes are urolithiasis, and urethral plugs which usually result when an attack of feline idiopathic cystitis is not self-limiting and escalates into a blockage of the bladder (i.e. obstructive FIC). Urinary tract ...
Domestic cats are affected by over 250 naturally occurring hereditary disorders, many of which are similar to those in humans, such as diabetes, hemophilia and Tay–Sachs disease. [ 3 ] [ 5 ] For example, Abyssinian cat 's pedigree contains a genetic mutation that causes retinitis pigmentosa , which also affects humans.
Mavacamten, sold under the brand name Camzyos, is a medication used to treat obstructive hypertrophic cardiomyopathy. [8] [9]Mavacamten is a small-molecule allosteric [10] and cardiac myosin inhibitor. [8]
Hypertrophic cardiomyopathy screening is an assessment and testing to detect hypertrophic cardiomyopathy (HCM). [ 1 ] [ 2 ] It is a way of identifying HCM in immediate relatives of family members diagnosed with HCM, and athletes as part of a sports medical . [ 3 ]